First Page | Document Content | |
---|---|---|
![]() Date: 2015-04-22 23:39:46Health economics B-cell chronic lymphocytic leukemia Lymphocytic leukemia Lymphoma Orphan drugs Leukemia Chlorambucil End point of clinical trials Rituximab Medicine Oncology Health | Source URL: www.pbs.gov.auDownload Document from Source WebsiteFile Size: 216,60 KBShare Document on Facebook |
![]() | PROTOCOLOTratamiento con Medicamentos Biológicos, Abatacept o Rituximab en adultos con Artritis Reumatoide refractaria al tratamiento habitualDocID: 1trGJ - View Document |
![]() | Oncogene, 3530–3540 & 2004 Nature Publishing Group All rights reserved $25.00 www.nature.com/onc Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10DocID: 1tpiT - View Document |
![]() | NOVEMBER 2015 TABLE OF CONTENTS INTRODUCTIONDocID: 1qUAB - View Document |
![]() | www.edoriumjournals.com CASE REPORT PEER REVIEWED | OPEN ACCESSDocID: 1qwuZ - View Document |
![]() | Zevalin Enlarged PI (Page 2)DocID: 1qhPE - View Document |